(Q44522035)

3 December 2017

0 references

1 reference

title

The HOPE Study (Heart Outcomes Prevention Evaluation). (English)

1 reference

3 December 2017

Sleight P

1

1 reference

3 December 2017

publication date

1 March 2000

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

3 December 2017

published in

1 reference

3 December 2017

volume

1

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

18-20

1 reference

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.002

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2000.002

0 references

1 reference